コネチカット州における悪性黒色腫の臨床試験
コネチカット州内の拠点で、悪性黒色腫に関する13件の研究が参加者を募集しています。
コネチカット州内の都市
公式研究テキスト（英語）
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Yale Cancer Center, New Haven
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478Phase 1 Study of PF-08046033 in Advanced Solid Tumors
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07519655A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Yale Cancer Center, New Haven
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06246916Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients
- Hartford Hospital, Hartford
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06284590A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Hartford Healthcare, Hartford
- Yale University, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/02更新 · NCT07070232Project: Every Child for Younger Patients With Cancer
- Connecticut Children's Medical Center, Hartford
- Yale University, New Haven
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244Integrated Cancer Repository for Cancer Research
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- Yale School of Medicine, North Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/28更新 · NCT06413680SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hartford
- Massive Bio SYNERGY-AI site, Norwalk
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Yale University, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/02/13更新 · NCT05669430Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Smilow Hospital Care Center, Guilford, Guilford
- Yale University, New Haven
被験者募集中
18歳以上 · 全性別 · 2024/11/27更新 · NCT03860883Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Yale Cancer Center, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2024/11/15更新 · NCT04787042Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
- Yale, New Haven
被験者募集中第2相
18歳以上 · 全性別 · 2024/03/18更新 · NCT05280314ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。